CN Patent
CN102202714A — 鼻用喷射装置
Assigned to Merck Sharp and Dohme LLC · Expires 2011-09-28 · 15y expired
What this patent protects
一种用于将至少一个剂量的组合物输送进入鼻腔中的输送装置(10),该装置具有成形用以插入鼻腔中的排出构件(12),排出开口(20)成形穿过排出构件,以及包含至少一个剂量(24)的贮存器的主体(14),所述主体是细长的并且大致沿着纵向轴线(16)延伸,其中排出构件(12)沿着第二轴线(18)延伸,第二轴线(18)与纵向轴线(16)交叉并相对于纵向轴线(16)横向布置。
USPTO Abstract
一种用于将至少一个剂量的组合物输送进入鼻腔中的输送装置(10),该装置具有成形用以插入鼻腔中的排出构件(12),排出开口(20)成形穿过排出构件,以及包含至少一个剂量(24)的贮存器的主体(14),所述主体是细长的并且大致沿着纵向轴线(16)延伸,其中排出构件(12)沿着第二轴线(18)延伸,第二轴线(18)与纵向轴线(16)交叉并相对于纵向轴线(16)横向布置。
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.